Position in FATE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$42,386
+$10,812 QoQ
Shares Held
35,322
+9.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Derivatives in FATE
reported options exposure · as of Jun 30, 2021CallValue
$26,037
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names. FATE ranks #88 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,200 | $58,503,546 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
58,925 | $45,527,812 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,859 | $35,025,567 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,684 | $29,330,533 | |
| 5 | RPRX |
Royalty Pharma plc
|
292,921 | $14,051,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
56,633 | $9,572,109 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
146,462 | $9,183,167 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
13,914 | $7,283,561 |
All Filings in FATE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,386 | 35,322 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $31,574 | 32,219 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $46,872 | 37,200 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $41,664 | 37,200 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $8,058 | 10,200 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $16,830 | 10,200 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $37,100 | 10,600 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $36,749 | 11,204 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $81,474 | 11,100 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $40,766 | 10,900 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $33,858 | 15,971 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $76,973 | 16,171 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $94,939 | 16,656 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $159,169 | 15,775 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $391,480 | 17,469 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $258,951 | 10,450 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $711,855 | 18,361 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,014,855 | 17,345 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $780,171 | 13,163 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,184,683 | 13,650 | Shares | Sole | 2021-08-06 | |
| 2021-06-30 | $26,037 | 300 | Call | Sole | 2021-08-06 | |
| 2021-03-31 | $540,212 | 6,552 | Shares | Sole | 2021-05-10 | |
| 2021-03-31 | $82 | 1 | Put | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||